Skip to main content
Caplight Logo









Ascendia

Ascendia

Private
ZugHealthcare & Life Scienceshttps://ascendiapharma.com

Company Overview

Ascendia operates in Healthcare & Life Sciences and is based in Zug. It was founded in 2017.

Ascendia is a blockchain technology company that develops a sovereign Layer-1 blockchain platform for autonomous AI agents and decentralized applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Ascendia Comparables

Compare Ascendia with similar companies based on industry and business-model similarity.

Ascendia comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AustinPx
85%
Quotient Sciences
82%
Adare Pharma Solutions
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Ascendia Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for Ascendia. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Todd R. Daviau

Chief Operating Officer, Member Board Of Directors

Executive Team

Robert Bloder

Chief Business Officer & Board Member, Member Board Of Directors

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 7, 2025

    Monthly visitors grew 331% MoM, reaching 79.9K.

  • Jun 2, 2025

    Monthly visitors increased 55% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Ascendia Filings

Explore SEC and related filing metadata, where available.

Ascendia filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Ascendia's valuation, stock price, and market status.

Is Ascendia a public or private company?

Ascendia is a private company.

What is the current stock price of Ascendia?

Ascendia is a private company, so its shares have no public market price. Caplight tracks Ascendia's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Ascendia worth (valuation)?

Valuation information for Ascendia is not publicly available.

Can I buy Ascendia stock?

Ascendia shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Ascendia's last funding round?

Funding round information for Ascendia is not publicly available.

Who are the main investors in Ascendia?

Investor information for Ascendia is not publicly disclosed.

Will Ascendia IPO soon?

No public IPO plans have been announced for Ascendia.

How can I track Ascendia secondary market activity?

Caplight tracks bids, offers, and trades in Ascendia's shares on secondary markets.

Firmographic Details

HeadquartersZug
Employee Range32
Year Founded2017
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?